Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke | MicrobiomeTrials← Back to trialsNCT07730840
Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-10-15Est. Completion: 2029-09-30
Enrollment target: 984 participants Locations- Asan Medical Center, Seoul, South Korea
Other microbiome trials you might be interested in
Atrial Fibrillation (AF)
The goal of this clinical trial is to learn if the cardiac pulsed field ablation system, composed of the cardiac pulsed …
Multiple LocationsEst. completion Mar 2028
Arteriosclerosis Obliterans
This study is a prospective, single-center, observational study. In this study, we aim to evaluate the clinical outcome …
Guangzhou, ChinaEst. completion Jul 2027
Intracerebral Hemorrhage
Stroke
Stroke, Acute
Stroke, Ischemic
Stroke Hemorrhagic
Stroke (CVA) or TIA
Brain Diseases
Background Reperfusion therapies, i.e., intravenous thrombolysis (IVT) and/or endovascular thrombectomy (EVT), are most …
Hong Kong, Hong KongEst. completion Dec 31, 2027